Cardinal Health, Inc. (CAH) earnings
CAH earnings moved a median of +1.11% by the close. Quarterly and annual CAH reports and results, each read against the price at its own news timestamp. Back to the CAH overview →
21 measured CAH earnings events.
Where these CAH earnings landedvs 20 measured CAH earnings reactions
| Middle 50% of CAH earnings reactions | -0.03% to +3.10% |
|---|---|
| Median reaction (to close) | +1.11% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 CAH earnings events with a measured close landed between -0.03% and +3.10%; 75% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5 | Press release | +0.84% | +1.12% | |
| Form 10-K CARDINAL HEALTH INC For: Jun 30 | SEC filing · Form 10-K | +4.19% | -1.94% | |
| Form 10-Q CARDINAL HEALTH INC For: Mar 31 | SEC filing · Form 10-Q | -2.53% | -1.23% | |
| Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 | Press release | -0.40% | +0.15% | |
| Form 10-Q CARDINAL HEALTH INC For: Dec 31 | SEC filing · Form 10-Q | +3.58% | +4.69% | |
| Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5 | Press release | +0.07% | +1.47% | |
| Form 10-Q CARDINAL HEALTH INC For: Sep 30 | SEC filing · Form 10-Q | +4.29% | +3.74% | |
| Cardinal Health to Announce First-Quarter Results for Fiscal Year 2026 on October 30 | Press release | +1.66% | +4.06% | |
| Form 10-K CARDINAL HEALTH INC For: Jun 30 | SEC filing · Form 10-K | +0.88% | — | |
| Form 10-Q CARDINAL HEALTH INC For: Mar 31 | SEC filing · Form 10-Q | +5.26% | +6.45% | |
| Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2025 on May 1 | Press release | -0.26% | -0.60% | |
| Form 10-Q CARDINAL HEALTH INC For: Dec 31 | SEC filing · Form 10-Q | +3.29% | +0.86% | |
| Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30 | Press release | +0.57% | +1.10% | |
| Form 10-Q CARDINAL HEALTH INC For: Sep 30 | SEC filing · Form 10-Q | +4.32% | +2.89% | |
| Cardinal Health to Announce First-Quarter Results for Fiscal Year 2025 on November 1 | Press release | -0.49% | -0.85% | |
| Form 10-K CARDINAL HEALTH INC For: Jun 30 | SEC filing · Form 10-K | -1.71% | -1.52% | |
| Form 10-Q CARDINAL HEALTH INC For: Mar 31 | SEC filing · Form 10-Q | +1.50% | +2.37% | |
| Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2 | Press release | +0.00% | +0.54% | |
| Form 10-Q CARDINAL HEALTH INC For: Dec 31 | SEC filing · Form 10-Q | -1.41% | +1.06% | |
| Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1 | Press release | +0.41% | +1.93% | |
| Form 10-Q CARDINAL HEALTH INC For: Sep 30 | SEC filing · Form 10-Q | +3.48% | +4.09% |
Keep exploring
More CAH: analyst actions → · SEC filings → · CAH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. (LXRX) | 339 | +0.29% | 51% |
| Cellect Biotechnology Ltd. - American Depositary Shares (APOP) | 337 | -0.42% | 35% |
| MannKind Corporation (MNKD) | 335 | -0.25% | 43% |
| Protagonist Therapeutics, Inc. (PTGX) | 335 | -0.24% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.